Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 106 Carcinoma, Non-Small-Cell Lung 34 Carcinoma, Renal Cell 23 Prostatic Neoplasms 17 Neoplasms 15 Brain Neoplasms 15 Neoplasm Metastasis 14 Lung Neoplasms 12 Breast Neoplasms 11 Uveal Melanoma 10 Pancreatic Neoplasms 10 Sarcoma 9 Small Cell Lung Carcinoma 7 Urinary Bladder Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Kidney Neoplasms 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Carcinoma, Transitional Cell 6 Carcinoma, Hepatocellular 6 Skin Neoplasms 5 Ovarian Neoplasms 5 Histiocytoma, Malignant Fibrous 5 Colorectal Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Recurrence 4 Neuroendocrine Tumors 4 Mesothelioma 4 Glioblastoma 4 Colonic Neoplasms 4

Interventions

Platinum Compounds 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Squamous-Cell Lung Cancer × Ipilimumab × Clear all

NCT03823625 2020-03-25

SQUINT

Fondazione Ricerca Traslazionale

Phase 2 Unknown

Squamous-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡